Suzlon Q2: Margin Recovery in Focus as Order Momentum Builds
After Q1's profit compression despite 23% revenue growth, the Street watches for EBITDA margin rebound toward full-year guidance. A 6.2 GW order book and four major wins since August set up execution credibility. Current stock down 55% from ATH—consensus ₹64 target sees 65% upside.
The Setup: Margin Recovery Is the Print
Suzlon opened FY27 with a two-speed result: revenue momentum was robust (₹3,819 Cr, +23% YoY on highest-ever Q1 wind-turbine deliveries of 506 MW), but profit went backward. Consolidated PAT fell 6% YoY to ₹305 Cr—a troubling signal amid revenue growth. The culprit: EBITDA margin compressed to 15.6%, well below management's full-year guidance of 17–18%. Management attributed the gap to supply-chain challenges and one-time costs that should normalize as volumes ramp. For Q2, the Street will be watching whether Suzlon can reclaim that margin trajectory while keeping revenue growth on pace. The absolute profit number matters less than the trajectory: if margins stay depressed, the growth story loses credibility.
~₹3,600–3,750 Cr
on-plan 20%+ YoY growth; Q1 was ₹3,819 Cr
~17–18%
recovery from Q1's 15.6%; full-year guidance is 17–18%
~₹350–380 Cr
if margin recovers; critical confidence flag
6.2 GW
growing; Q2 inflow tracked at 755.6 MW in past two months
What a strong Q2 looks like: Margin recovery toward 17% or above, steady revenue growth (₹3,600+ Cr), and PAT stabilization or growth. Confirmation that supply-chain headwinds are easing and the company is tracking its full-year guidance. Order inflow continues >200 MW/month. What a weak Q2 looks like: Margin stays below 16%, suggesting either structural cost issues or delayed normalization. Revenue slowdown below ₹3,600 Cr. PAT remains depressed. Forward guidance is revised or cautious on margin recovery.
On Track? The Full-Year Trajectory
Suzlon's core narrative hinges on two things: (1) order inflow momentum, and (2) margin normalization. Q1 delivered on (1)—the 506 MW delivery (highest Q1 ever) proves the order book is moving into production. But Q1 stumbled on (2). Q2 is the retest. If margins stay compressed, the company must offer credible guidance on when they normalize—or face questions about the business model's sustainability at scale. With two quarters left in FY27, there's still time to steer toward full-year guidance (17–18% EBITDA margin), but Q2 is the critical checkpoin. The 6.2 GW order book is firm enough; the debate is purely on margin trajectory.
What the Street Says
Since Last Quarter: Filings & Business Updates
1 · Order Inflow Acceleration (Aug–Sep 2026)
Four major wins in eight weeks: Ayana Renewable Power (200 MW, Sep 8), Torrent Green Energy (250 MW, Aug 25), Waaree Forever Energies (201.6 MW, Jul 23), and Sunsure Energy (105 MW, Jun 30). Total: 755.6 MW of order inflow in Q2 period. All orders signed and material for near-term execution. The Sunsure win is noteworthy—it's the maiden order for Suzlon's new S175 (5.0 MW) platform, validating the company's technology roadmap. This validates the 6.2 GW order book and supports the full-year delivery guidance.
2 · Management Changes (Jul–Sep 2026)
Two leadership moves, both benign. Ms. Manjari Upadhye appointed as President – RE Asset Management Services (Sep 4), a new role reporting to the Group CEO. This suggests focus on the asset-management business (likely wind parks / power generation), a higher-margin adjacent business. Mr. Rajendra Mehta exited as Group Chief HR Officer (Jul 28) due to health reasons—routine separation. No red flags; the org chart continues to evolve as the business scales.
3 · Price Clarifications (Jul–Oct 2026)
No material news identified. The company filed Material Price Movement clarifications on Jul 28, Oct 8, and Oct 13, stating that no identifiable event or news precipitated the price swings. This is typical defensive filing; the stock's broad weakness is sector/macro driven (renewable energy cyclicality, wind-farm financing dynamics), not company-specific. No insider selling or pledge activity disclosed.
4 · Governance & ESG (Aug 2026)
Routine filings. Annual Report (FY 2025–26) released Aug 15 with Business Responsibility & Sustainability Report; 31st AGM held Sep 11. One typographical correction to the Annual Report (flag swaps on pages 49 and 178–183). No material governance issues; the company is compliant with Board-mandated Audit Committees and insider-trading protocols (trading window closed Sep 24 – 48 hrs post-result announcement).
The Setup in One Paragraph
Suzlon heads into Q2 results on Oct 29 as a margin-recovery story. Q1 proved order inflow is real and sustainable (506 MW deliveries, highest-ever Q1; 6.2 GW order book). But it also showed that ramping volume at scale is squeezing EBITDA below management guidance. The Street is solidly constructive (Strong Buy at ₹64, 65% upside)—but that thesis only holds if the company can demonstrate that the Q1 margin dip was a one-time supply-chain effect, not a structural problem. Four major orders won in Q2 (755.6 MW) validate the business momentum. The next 48 hours will tell investors whether Suzlon is on a path to the 17–18% margins it promised for the year.
What to Watch on Result Day
1 · EBITDA margin—can it get back to 17%?
The absolute profit number is secondary. If Q2 EBITDA margin is 17% or above, the Street will read it as a normalized run-rate and the stock could re-rate up. If it stays at 15–16%, prepare for guidance caveats and a softer investor reaction. This is the thesis-making number.
2 · MW delivered in Q2—any slowdown vs Q1's 506 MW?
Volume is the near-term growth lever. If Q2 deliveries are ≥500 MW and margin recovers, both parts of the story align. A slowdown to <450 MW + margin dip would signal demand weakness or execution friction.
3 · FY27 and FY28 guidance—any revision or new color?
Management will likely discuss supply-chain normalization, pricing environment, and the outlook for the 6.2 GW order book. Any shift in full-year margin guidance or order-intake expectations will drive valuation. Positive commentary on H2 execution is the bull-case confirmation.
Suzlon's Q2 FY27 results on Oct 29 are a clean margin-recovery binary. Order inflow has validated the business momentum; execution on margin is the remaining variable. The Street is already positioned constructively (Strong Buy at ₹64), which means Q2 is a confirmation or disappointment, not a surprise. A 17%+ EBITDA margin print and steady MW delivery would reaffirm the full-year guidance path and likely support a stock re-rating back toward the ₹62–64 consensus target (currently 55% below ATH at ₹86). Weakness below 17% margin or cautious guidance would invite profit-taking despite the order book strength.